Evaluation of microRNAs as novel markers of cardiotoxicity in children undergoing anthracycline therapy for pediatric cancer

Complete Title: Evaluation of microRNAs as novel markers of cardiotoxicity in children undergoing anthracycline therapy for pediatric cancer
Trial Phase: N/A
Investigator: Kasey Leger

Keywords:
  • Pediatric Cancers, Miscellaneous
  • Cardiovascular Diseases
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Pediatric
N/A
Kasey Leger
SC-B610
Evaluation of microRNAs as novel markers of cardiotoxicity in children undergoing anthracycline therapy for pediatric cancer
Pediatric Cancers, Miscellaneous
Cardiovascular Diseases